Showing results (431-440 of 652) with videos related to

Sort By:
Pageof 66
Journal of Cardiovascular Electrophysiology|January 21, 2021
Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: A systematic review and meta-analysisSamuel J Tu, Nicole Hanna-Rivero, Adrian D Elliott, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2009
Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritisSamih H Nasr, Samar M Said, Anthony M Valeri, et al.
Journal of Hypertension|March 31, 2009
Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl ratsWilliam M Manger, Shlomoh Simchon, Michael B Stokes, et al.
Heart Rhythm|March 26, 2008
Image integration using NavX Fusion: initial experience and validationAnthony G Brooks, Lauren Wilson, Pawel Kuklik, et al.
Journal of Cardiovascular Electrophysiology|February 28, 2008
The effect of electrogram duration on quantification of complex fractionated atrial electrograms and dominant frequencyMartin K Stiles, Anthony G Brooks, Bobby John, et al.
The Canadian Journal of Cardiology|October 4, 2021
Prevalence and Assessment of Sleep-Disordered Breathing in Patients With Atrial Fibrillation: A Systematic Review and Meta-analysisKadhim Kadhim, Melissa E Middeldorp, Adrian D Elliott, et al.
Heart Rhythm|May 16, 2026
Right Ventricular Dysfunction in Patients with Symptomatic Atrial Fibrillation: Prevalence and Functional ImplicationsJenelle K Dziano, Jonathan P Ariyaratnam, Jackson Howie, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626,603 Individuals in 51 StudiesChristopher X Wong, Thomas Sullivan, Michelle T Sun, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Thrombogenic Risk in Patients With Atrial Fibrillation: Importance of Comorbid Conditions and Intracardiac ChangesHan S Lim, Scott R Willoughby, Carlee Schultz, et al.
Heart Rhythm O2|December 8, 2025
Cardiac resynchronization therapy and AV node ablation in heart failure with reduced ejection fraction and atrial fibrillation: Rationale and design of the CAAN-AF trialPrashanthan Sanders, Jonathan P Ariyaratnam, Alexis Puvrez, et al.
Pageof 66